“Nobody has sunk into a hole that’s too deep to climb out of,” says Brian Dawson, M.D., chief medical officer of Ideal Option and a specialist in both addiction and emergency medicine. “With the right kind of support, anyone can turn their life around.”
This Story of Hope features Everett, now in recovery, who had used drugs off and on since age 18 due to hanging out with the wrong crowd.
This Story of Hope features Hunter, who fell victim to addiction at age 16 when he began using heroin to cope with his depression.
This Story of Hope features Jennifer, now 8 years in recovery, who fell victim to pain pill addiction in her early teens.
This Story of Hope features Adriana, now in recovery, who fell victim to addiction when her boyfriend introduced her to pain pills to treat her stress.
In the fentanyl era, good news is scarce — opioids kill more than 80,000 Americans a year. But a new injectable medication has left addiction medicine providers feeling downright hopeful.
This Story of Hope features Roy, now nearly 4 years in recovery, who fell victim to addiction after his girlfriend introduced him to heroin.
This Story of Hope features Jane, now 4 years in recovery, who fell victim to opioid addiction when she received a prescription for back pain.
First came fentanyl. Then xylazine, aka “tranq,” a veterinary sedative. Will nitazines, a dangerous new class of synthetic opioid, infiltrate the drug supply next?
“Our theory is, it’s just a matter of time,” says Brian Dawson, M.D., an addiction medicine specialist and Chief Medical Officer for Ideal Option. “We could be looking at the very beginning of a nitazine wave.”
Since its approval in 2002, Suboxone has proven miraculous for countless patients struggling with opioid use disorder (OUD). Taken daily, as a film that dissolves under the tongue, the medication suppresses withdrawal symptoms and…